Cardinal Health (NYSE:CAH) Stock Price Expected to Rise, Mizuho Analyst Says

Cardinal Health (NYSE:CAH) had its price target boosted by equities research analysts at Mizuho from $142.00 to $150.00 in a research note issued to investors on Monday,Benzinga reports. The brokerage currently has an “outperform” rating on the stock. Mizuho’s price target would indicate a potential upside of 9.33% from the stock’s current price.

Several other brokerages have also weighed in on CAH. Argus set a $148.00 price objective on Cardinal Health in a report on Tuesday, February 4th. JPMorgan Chase & Co. boosted their price target on shares of Cardinal Health from $142.00 to $145.00 and gave the stock a “neutral” rating in a research report on Tuesday, February 4th. Bank of America upgraded shares of Cardinal Health from a “neutral” rating to a “buy” rating and raised their price objective for the company from $132.00 to $145.00 in a research report on Monday, January 6th. TD Cowen upgraded shares of Cardinal Health from a “hold” rating to a “buy” rating and boosted their target price for the stock from $130.00 to $144.00 in a report on Wednesday, January 8th. Finally, Citigroup increased their target price on shares of Cardinal Health from $120.00 to $129.00 and gave the company a “neutral” rating in a research note on Friday, January 10th. Four analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $140.14.

Cardinal Health Stock Performance

CAH stock opened at $137.20 on Monday. Cardinal Health has a 1 year low of $93.17 and a 1 year high of $138.62. The stock has a market capitalization of $33.14 billion, a price-to-earnings ratio of 25.60, a PEG ratio of 1.49 and a beta of 0.66. The stock’s fifty day moving average is $128.78 and its two-hundred day moving average is $121.20.

Cardinal Health (NYSE:CAH) last announced its earnings results on Thursday, January 30th. The company reported $1.93 earnings per share for the quarter, beating the consensus estimate of $1.74 by $0.19. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. As a group, analysts predict that Cardinal Health will post 7.95 EPS for the current fiscal year.

Hedge Funds Weigh In On Cardinal Health

Institutional investors have recently made changes to their positions in the business. Cyrus J. Lawrence LLC acquired a new position in shares of Cardinal Health during the fourth quarter worth approximately $26,000. Promus Capital LLC bought a new position in Cardinal Health during the fourth quarter worth $30,000. Bellwether Advisors LLC acquired a new position in Cardinal Health during the 4th quarter valued at $32,000. Lee Danner & Bass Inc. bought a new stake in Cardinal Health in the 4th quarter valued at $35,000. Finally, Itau Unibanco Holding S.A. acquired a new stake in Cardinal Health in the 4th quarter worth $36,000. 87.17% of the stock is currently owned by institutional investors.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.